Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
ClarityTek is a U.S.-based digital health and VR therapeutics R&D company located in Minnesota, with a core focus on Virtual Reality Cognitive Therapy (VRCT). Its flagship product targets patients with mild cognitive impairment and early-stage Alzheimer’s disease, emphasizing at-home cognitive rehabilitation. The goal is not to create generic brain-training games, but to train memory, attention, executive function, and independence in daily living around IADL (Instrumental Activities of Daily Living).
VRCT uses immersive, low-distraction virtual environments and breaks tasks such as name-face recognition, short-term to-do memory, common object memory, shopping, budgeting, and planning into structured modules. The workflow includes onboarding training, strategy explanations, guided practice, real-time feedback, recall checks, and closed-loop difficulty adjustment based on performance. Its training methods include compensatory memory strategies such as spaced retrieval, spatial anchors, the Method of Loci, Peg System, and Link System.
On the AI side, the website states that its assessment module uses explainable AI and machine learning, combining MR images and other biomarkers to identify Alzheimer’s disease, and using AI progression models to support diagnosis, prediction, and prognosis. However, the main content does not disclose specific algorithms, dataset size, accuracy, or model validation details. It is therefore better understood as an “AI-assisted assessment/prediction capability,” rather than a fully transparent, publicly documented AI platform.
ClarityTek is backed by NIH/NIA SBIR funding and discloses R43AG076169 as well as the clinical study NCT05788848. The research focus includes IADL improvement, usability, and safety. The website also mentions early signals from at-home deployment: approximately 85% usability, approximately 94.4% feasibility, and most participants using it at least three times per week. Pricing, trials, insurance reimbursement, purchasing process, specific VR headset models, APIs, and hospital system integration methods are not disclosed.
The main advantage is its clear positioning: it focuses on real-life functional ability at home, with scenarios that are more relevant to patients and caregivers than ordinary cognitive mini-games. It also has clinical partnerships, an NIH background, and a design oriented toward remote home use. The drawbacks are also clear: commercialization details are limited, and key medical software information such as privacy compliance, data storage, and HIPAA is not reflected in the main text. Its effectiveness still needs to be supported by more clinical results.
Mainland China access, Chinese interface, Chinese voice/content, local payment, and medical compliance are not specified, so china_access can only be considered unknown. If deployed in China, key evaluation areas would include network accessibility, VR hardware supply, cross-border compliance for patient data, adaptation of Chinese-language cognitive training content, and hospital ethics approval. Alternatives may include digital therapeutics from local hospital rehabilitation departments, VR rehabilitation training systems, and cognitive training software, but each should be compared item by item based on clinical evidence.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on claritytek.com official site.
claritytek.com is an United States AI Apps provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach claritytek.com directly.